课题基金 / 基金详情

Effectiveness of ghrelin receptor agonists to limit the extent of tissue damage caused by traumatic injury to the central nervous system

Effectiveness of ghrelin receptor agonists to limit the extent of tissue damage caused by traumatic injury to the central nervous system
生长素释放肽受体激动剂对限制中枢神经系统创伤性损伤引起的组织损伤程度的有效性
批准号:
nhmrc : 1049287
负责人:
Dr Mark Habgood
金额:
$39.47万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2015-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ghrelin is a naturally occurring compound that under adverse conditions can activate specific receptors on cells around the body to enhance their survival. These receptors are also present in the spinal cord, but ghrelin doesn't enter the spinal cord. We will investigate a new group of compounds that can enter the spinal cord and activate these receptors to see if this can reduce the amount of damage that occurs after a spinal cord injury. Less tissue damage would mean less permanent disability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
青鲫ghrelin基因对生长和摄食性状的共调控机制研究
  • 批准号:
    2025JJ50144
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    张运生
  • 依托单位:
Ghrelin通过lncRNA_TLR2作用于NF-κB/NLRP3/GSDMD轴抑制血管内皮细胞焦亡改善急性创伤性凝血病的研究
  • 批准号:
    2025JJ81081
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    贺承健
  • 依托单位:
电针介导Ghrelin/GHSR 1α/PD-L1/PD-1通路调控免疫稳态 减轻脓毒症肠道损伤的机制
  • 批准号:
    2024JJ9099
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    欧好
  • 依托单位: